Mast cell activation in Dowling-Degos disease

Br J Dermatol. 2019 Dec;181(6):1312-1314. doi: 10.1111/bjd.18221. Epub 2019 Aug 22.

Authors

J Knuever¹, O D Persa¹, A Illerhaus¹, D J Ralser², K Hartmann^{1

3}, R C Betz², I Tantcheva-Poór¹

Affiliations

¹ Department of Dermatology, University of Cologne, Cologne, Germany.
² Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
³ Division of Allergy, Department of Dermatology, University of Basel, Basel, Switzerland.

PMID: 31206596
DOI: 10.1111/bjd.18221

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Biopsy
DNA Mutational Analysis
Diagnosis, Differential
Female
Glucosyltransferases / genetics
Histamine Antagonists / administration & dosage
Humans
Hyperpigmentation / complications
Hyperpigmentation / diagnosis
Hyperpigmentation / genetics
Hyperpigmentation / immunology*
Keratin-5 / genetics
Mast Cells / drug effects
Mast Cells / immunology*
Mastocytosis / diagnosis
Mutation
Pruritus / drug therapy
Pruritus / immunology*
Skin / cytology*
Skin / immunology
Skin / pathology
Skin Diseases, Genetic / complications
Skin Diseases, Genetic / diagnosis
Skin Diseases, Genetic / genetics
Skin Diseases, Genetic / immunology*
Skin Diseases, Papulosquamous / complications
Skin Diseases, Papulosquamous / diagnosis
Skin Diseases, Papulosquamous / genetics
Skin Diseases, Papulosquamous / immunology*

Substances

Histamine Antagonists
KRT5 protein, human
Keratin-5
Glucosyltransferases
POGLUT1 protein, human

Supplementary concepts

Dowling-Degos Disease